MEDICINA
Departamento
Philips Healthcare España
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Philips Healthcare España (3)
2018
-
Mirabegron, a Clinically Approved β3 Adrenergic Receptor Agonist, Does Not Reduce Infarct Size in a Swine Model of Reperfused Myocardial Infarction
Journal of Cardiovascular Translational Research, Vol. 11, Núm. 4, pp. 310-318
2015
-
Prevalence, vascular distribution, and multiterritorial extent of subclinical atherosclerosis in a middle-aged cohort the PESA (Progression of Early Subclinical Atherosclerosis) study
Circulation, Vol. 131, Núm. 24, pp. 2104-2113
2014
-
Long-term benefit of early pre-reperfusion metoprolol administration in patients with acute myocardial infarction: Results from the Metocard-CNIC trial (Effect of Metoprolol in Cardioprotection during an Acute Myocardial Infarction)
Journal of the American College of Cardiology, Vol. 63, Núm. 22, pp. 2356-2362